AHCCCS Pharmacy Information

Pharmacy Updates

Updated Synagis Coverage 2024-2025

Human Respiratory Syncytial Virus (RSV) causes respiratory tract infections and serious lung disease in infants and children. Synagis (palivizumab) is available for children that are at high risk for RSV."

The AHCCCS Pharmacy & Therapeutics Committee (Committee) is advisory to the AHCCCS Administration and is responsible for evaluating scientific evidence of the relative safety, efficacy, effectiveness and clinical appropriateness of prescription drugs. The Committee makes recommendations to the AHCCCS Administration on the development and maintenance of a statewide drug list and prior authorization criteria as appropriate. The Committee may also evaluate individual drugs and therapeutic classes of drugs.

The meetings are open to the public.

P&T Meeting Public Testimony, for persons that are not representing a pharmaceutical company, pharmacy benefit manager or related entity, may be given orally or submitted as a written document in accordance with the AHCCCS P&T Operational Policy

Each person must fill out the Public Testimony Registration Form and the Conflict of Interest Form to register for the meeting. See the AHCCCS P&T Operational Policy for deadlines.

Magellan Medicaid Administration, Inc. (MMA), part of the Magellan Rx Management division of Prime Therapeutics LLC, has been selected to manage the preferred drug list (PDL) and supplemental rebate processes. Please see the MagellanRX Management site for more information.

P&T Meeting and Class Review Schedule

October 15, 2024

  • Non-Supplemental Repeat Classes Review:
    • Antimigraine Agents-Triptans
    • Leukotriene Modifiers
    • Phosphate Binders
    • Sedative Hypnotics
    • Topical Steroids by Potency (low, medium, high, very high)
    • Antifungals-Oral
    • Antifungals- Topicals
    • Beta Blockers
    • BPH Treatments
    • Calcium Channel Blockers
    • HIV-AIDS
    • Movement Disorders

January 29, 2025

  • Non-Supplemental Rebate Classes Review:
    • Antidepressants - Other
    • Antidepressants - SSRIs
    • Beta Agonist Bronchodilators
    • Bone Resorption Suppression and Related Agents
    • Colony Stimulating Factors
    • Enzyme Replacement - Gauchers Disease
    • Erythropoiesis Stimulating Proteins
    • Hypoglycemics - Alpha-Glucosidase Inhibitors
    • Hypoglycemics - Metformins
    • Hypoglycemics - SGLT2s
    • Immune Globulins
    • Oncology, Oral - Hematologic
    • Ophthalmics – Anti-Inflammatory/Immunomodulators
    • Otic Antibiotics
    • PAH Agents - Oral and Inhaled
    • Thrombopoiesis Stimulating Proteins

Agendas & Meeting Minutes

ANNOUNCEMENT: All AHCCCS P&T meetings will be held virtually until further notice.

Current P&T Committee Member Information

P&T Application - Now Accepting New Members

The AHCCCS Pharmacy and Therapeutics Committee is now accepting new members for the following positions:

  • Health Care Providers - 1 Representative (Obstetrics and Gynecology)
  • Public - 2 Representatives (Inter-Tribal Council of Arizona and Medicaid Member)
  • AHCCCS MCO's and TRBHA - 2 Representatives (TRBHA Pharmacy Director and/or TRBHA Medical Director)
  • University Representative - 1 Representative (Researcher)

Please fill out the P&T Application and send to the Arizona Pharmacy Department ( AHCCCSPharmacyDept@azahcccs.gov ) for consideration.

For more information, you may contact the Pharmacy Department at AHCCCSPHARMACYDEPT@AZAHCCCS.GOV.

Archived pharmacy documents are available under ‘Pharmacy Updates’ in the AHCCCS Document Archive.